Member Info for Mars1

Anything can be scaled more. Where there is demand... supply will follow.

If they make 200k a week they hit the lower end of the broker valuation of £190m

Big Mac the upscale was 1m Elisa tests and 1m lateral flow tests not 200k

ODX obtained the CE mark for Mologic In the U.K. this is likely internationally also

46000 was the original temporary contract this was replaced when the other tests were added And 3 year contract was established. The potential revenue from a quote given to the Herald presumably from ODX given the Scottish connection should not be far out

From memory I believe that was potential revenue from Mologic for just the Elisa test. So gross profit. The only Operational cost will be staff. So margin above 70%. But production capacity for Elisa tests is being increased to 1m per week.

For Mologic Elisa tests the Herald said ODX would make £15 to £30m pa. this was when the max original contract was 46000 tests per day. So if we assume the max 46k x 5 days x 52 weeks is 12m tests.
£30m divide by 12m tests is £2.50. Mologic provide the raw materials.

1.4 b population, 603k cases up17k last 24hrs

Do you think everyone has an Elisa test for approval

They were buying additional kit but that will have been done for as soon as the 3 year contract was signed

Sorry s/be 1m per week it is 2m total

Elon ODX are upping capacity for Elisa to 2m per week

Govt promote exports for firms as a matter of course they have a whole dept purpose to stimulate jobs in U.K. there is no charge

This will bounce after the open offer the MMs want all the 40p shares themselves

Corunna thanks for the reminder £190m lower end value by the broker following the placing at 10% operational capacity . Value currently 41% of that. Interesting that ODX has already a significant US involvement via the Clinton Foundation and through Mologic who is supported by the Gates Foundation.

Anyone recall the minimum brokers value presumably that is where they would expect the value to be now?

The brokers upper end valuation from the placing document is £980m given capacity that is available. Only £902m to go.

I believe WHO confirmed each African country now has at least one laboratory

It’s 1m lateral flow and 1m Elisa tests per week. The lateral flow is 80/20 but can be moved between RTC and Mologic

So is the U.K. Gov going to sell them to all the Commonwealth before US